We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Carrier Testing Update

09 October 2015

Medical Device Alert

FDA today issued an update regarding 23andme’s Bloom Syndrome carrier testing de novo approval as a class II medical device.

Read more: Carrier Testing Update


Loading data